tumor-immunology-utrecht.nl Report : Visit Site

Technical data of the tumor-immunology-utrecht.nl

Geo IP provides you such as latitude, longitude and ISP (Internet Service Provider) etc. informations. Our GeoIP service found where is host tumor-immunology-utrecht.nl. Currently, hosted in United States and its service provider is Squarespace Inc. .

HTTP Header Analysis

HTTP Header information is a part of HTTP protocol that a user's browser sends to called containing the details of what the browser wants and will accept back from the web server.

DNS

HtmlToText

-- home team jürgen kuball eric spierings jaap-jan boelens jeanette leusen niels bovenschen monique minnema stefan nierkens victor peperzak zsolt sebestyén research advanced dendritic cell vaccines adoptive immunotherapy strategies next generation targeted antibody therapies cellular cytotoxicity and tumor immune evasion advanced immune monitoring for clinical trials news contact home team jürgen kuball eric spierings jaap-jan boelens jeanette leusen niels bovenschen monique minnema stefan nierkens victor peperzak zsolt sebestyén research advanced dendritic cell vaccines adoptive immunotherapy strategies next generation targeted antibody therapies cellular cytotoxicity and tumor immune evasion advanced immune monitoring for clinical trials news contact welcome to people clinical partners & trials vacancies at umc utrecht tumor immunology welcome to the umc utrecht tumorimmunolgy team develop innovative treatment strategies for improving the outcome and treatment of hematological cancers. scroll down welcome to the umc utrecht tumorimmunolgy team develop innovative treatment strategies for improving the outcome and treatment of hematological cancers. our mission: curing cancer while also improving quality of life background to unravel mechanisms how the human immune system protects us from developing cancer provides the key for novel therapies and generates most promising remedies for patients suffering from malignancies. mission the development and clinical application of innovative treatment strategies toward improving the outcome of hematological cancers and treatment associated (chronic) complications. approach to accomplish our mission, the research activities of the section applied / tumor immunology are concentrated in five fields of innovation: advanced therapeutic dendritic cell vaccines adoptive (engineered) immunotherapy strategies next generation targeted antibody therapies cellular cytotoxicity and tumor immune evasion advanced immune monitoring for clinical trial social relevance administering more efficient and less toxic therapies will allow not only treating younger and more elderly patients but also increasing the total number of cancer survivors with improved quality of life. people principal investigators at umc utrecht with different backgrounds such as biochemistry, biology, clinical translation and daily patient care work in close collaboration with academic and commercial partners to create innovative cancer therapies and treatments. people principal investigators at umc utrecht with different backgrounds such as biochemistry, biology, clinical translation and daily patient care work in close collaboration with academic and commercial partners to create innovative cancer therapies and treatments. jurgen kuball leukemia / allogeneic stem cell transplantation / tumor immunolgy / gvhd jaap jan boelens cord blood derived cell therapies / rare diseases / immune-reconstitution / pharmoco-kinetics & pharmaco-dynamics (pkpd) eric spierings transplantation / histocompatibility / hla / immunology zsolt sebestyen molecular interactions / cell membrane topography / tumor immunology / tcr signalling monique minnema multiple myeloma / morbus waldenstrom / phase i/ii clinical studies / immunotherapy stefan nierkens tumor immunology / dendritic cells / immune monitoring / allogenic stem cell transplantation niels bovenschen immunity / inflammation / tumor / granzyme jeanette leusen next generation therapeutic antibodies / fc receptors / innate effectorcells / iga / cancer / lung virus principal investigators achieving great things through strong teamwork. a comprehensive group of principal investigators dedicated to tumor immunology is located at the laboratory of translational immunology . a complementary composition of pis with different backgrounds such as biochemistry, biology, clinical translation, and daily patient care creates an environment in close collaboration with academic and commercial partners for novel and innovative therapies aiming to overcome some of the major medical challenges of today. groups jaap jan boelens (topic scout) and stefan nierkens niels bovenschen jurgen kuball (chair) and zsolt sebestyen jeanette leusen (co-chair) monique minnema and reinier raymakers eric spierings clinical partners & trials the team at umc utrecht work closely with local hospitals and study and research groups to achieve their aim of developing groundbreaking treatment and therapies for cancer patients. clinical partners & trials the team at umc utrecht work closely with local hospitals and study and research groups to achieve their aim of developing groundbreaking treatment and therapies for cancer patients. working with others our team works in close collaboration with: hospitals department of hematology, umc utrecht cancer center department of hematology, wilhemina kinder ziekehuis, umc utrecht princess maxima centrum study groups hovon skion meetings at the umcu monday 13.30 -14.30 research meeting section applied thursday 09.00-10.00 laboratory of translational immunology vacancies at umc utrecht tumor immunology vacancies for positions at umc utrecht arise from time to time. we look forward to hearing from you! vacancies at umc utrecht tumor immunology vacancies for positions at umc utrecht arise from time to time. we look forward to hearing from you! work with us current vacancies we currently have the folllowing vacancies: student positions more information about individual student projects can be found here . top umc utrecht heidelberglaan 100 3584 cx utrecht netherlands e: [email protected] t: +31 ( 0) 88 75 555 55 © 2015 universitair medisch centrum utrecht

URL analysis for tumor-immunology-utrecht.nl

http://www.tumor-immunology-utrecht.nl/#vacancies
http://www.tumor-immunology-utrecht.nl/monique-minnema/
http://www.tumor-immunology-utrecht.nl/cellular-cytotoxicity
http://www.tumor-immunology-utrecht.nl/jurgen-kuball
http://www.tumor-immunology-utrecht.nl/zsolt-sebestyn
http://www.tumor-immunology-utrecht.nl/next-generation-targeted-antibody-therapies/
http://www.tumor-immunology-utrecht.nl/eric-spierings/
http://www.tumor-immunology-utrecht.nl/jeanette-leusen/
http://www.tumor-immunology-utrecht.nl/#people
http://www.tumor-immunology-utrecht.nl/jaap-jan-boelens
http://www.tumor-immunology-utrecht.nl/advanced-immune-monitoring-for-clinical-trials/
http://www.tumor-immunology-utrecht.nl/next-generation-targeted-antibody-therapies
http://www.tumor-immunology-utrecht.nl/stefan-nierkens/
http://www.tumor-immunology-utrecht.nl/advanced-dendritic-cell-vaccines/
http://www.tumor-immunology-utrecht.nl/niels-bovenschen/

Whois Information

Whois is a protocol that is access to registering information. You can reach when the website was registered, when it will be expire, what is contact details of the site with the following informations. In a nutshell, it includes these informations;

Domain name: tumor-immunology-utrecht.nl
Status: active

Registrar:
GoDaddy.com
14455 N. Hayden Rd Suite 219
85260 Scottsdale
United States of America

Abuse Contact:

DNSSEC: no

Domain nameservers:
ns81.domaincontrol.com
ns82.domaincontrol.com

Record maintained by: NL Domain Registry

As the registrant's address is not in the Netherlands, the registrant is
obliged by the General Terms and Conditions for .nl Registrants to use
SIDN's registered office address as a domicile address. More information
on the use of a domicile address may be found at
https://www.sidn.nl/downloads/procedures/Domicile_address.pdf


Copyright notice
No part of this publication may be reproduced, published, stored in a
retrieval system, or transmitted, in any form or by any means,
electronic, mechanical, recording, or otherwise, without prior
permission of the Foundation for Internet Domain Registration in the
Netherlands (SIDN).
These restrictions apply equally to registrars, except in that
reproductions and publications are permitted insofar as they are
reasonable, necessary and solely in the context of the registration
activities referred to in the General Terms and Conditions for .nl
Registrars.
Any use of this material for advertising, targeting commercial offers or
similar activities is explicitly forbidden and liable to result in legal
action. Anyone who is aware or suspects that such activities are taking
place is asked to inform the Foundation for Internet Domain Registration
in the Netherlands.
(c) The Foundation for Internet Domain Registration in the Netherlands
(SIDN) Dutch Copyright Act, protection of authors' rights (Section 10,
subsection 1, clause 1).

  REFERRER http://www.domain-registry.nl

  REGISTRAR Stichting Internet Domeinregistratie NL

SERVERS

  SERVER whois.domain-registry.nl

  ARGS tumor-immunology-utrecht.nl

  PORT 43

  TYPE domain

DOMAIN

  NAME tumor-immunology-utrecht.nl

  STATUS active

SPONSOR
GoDaddy.com
14455 N. Hayden Rd Suite 219
85260 Scottsdale
United States of America
Abuse Contact:
DNSSEC: no

NSERVER

  NS81.DOMAINCONTROL.COM 216.69.185.81

  NS82.DOMAINCONTROL.COM 173.201.69.32

  REGISTERED yes

Mistakes

The following list shows you to spelling mistakes possible of the internet users for the website searched .